| Nr. | Year OPEN | Title | users say> | rate good | rate bad | no link | Citation |
ObesityGrowth hormoneGrowth retardation (Failure to thrive)Transition patientsPituitary gland (Insufficiency Panhypopituitarism)Growth plateIGF1Receptor (IGF1)Receptor (GH)GHRHPrenatal therapyGrowth retardation (Fetal IUGR)Neoplasia (Carcinogenesis)Mammary gland (Neoplasia)Atrazine| 1 | 1993 | Mechanisms by which somatotropin decreases adipose tissue growth. | 
| + | - | nl | Am J Clin Nutr 58(2 Suppl):287S-295S (1993) |
| 2 | 1999 | Neuroendocrine control of growth hormone secretion. | 
| + | - | nl | Physiol Rev 79(2):511-607 (1999) |
| 3 | 2008 | Growth hormone, insulin-like growth factors, and the skeleton. | 
| + | - | nl | Endocr Rev 29(5):535-59 (2008) |
| 4 | 2005 | Development of growth hormone secretagogues. | 
| + | - | nl | Endocr Rev 26(3):346-60 (2005) |
| 5 | 1998 | The diagnosis of growth hormone deficiency in children and adults. | 
| + | - | nl | Endocr Rev 19(2):203-23 (1998) |
| 6 | 1998 | Growth hormone and bone. | 
| + | - | nl | Endocr Rev 19(1):55-79 (1998) |
| 7 | 2004 | Clinical presentation and diagnosis: growth hormone deficiency in adults. | 
| + | - | nl | Am J Manag Care 10(13 Suppl):S424-30 (2004) |
| 8 | 2004 | Growth hormone secretion: molecular and cellular mechanisms and in vivo approaches. | 
| + | - | nl | Exp Biol Med (Maywood) 229(4):291-302 (2004) |
| 9 | 2006 | Evaluation and treatment of adult growth hormone deficiency: an Endocrine Society Clinical Practice Guideline. | 
| + | - | nl | J Clin Endocrinol Metab 91(5):1621-34 (2006) |
| 10 | 2004 | Clinical review 166: Growth hormone receptor antagonists. | 
| + | - | nl | J Clin Endocrinol Metab 89(4):1503-11 (2004) |
| 11 | 2003 | Adult-onset growth hormone deficiency: Relation of postprandial dyslipidemia to premature atherosclerosis. | 
| + | - | nl | J Clin Endocrinol Metab 88(6):2479-88 (2003) |
| 12 | 2000 | Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: summary statement of the GH Research Society. GH Research Society. | 
| + | - | nl | J Clin Endocrinol Metab 85(11):3990-3 (2000) |
| 13 | 1999 | Growth hormone resistance: clinical states and animal models. | 
| + | - | nl | J Endocrinol 163(2):165-72 (1999) |
| 14 | 2006 | New insights into growth hormone action. | 
| + | - | nl | J Mol Endocrinol 36(1):1-7 (2006) |
| 15 | 2006 | Negative regulation of growth hormone receptor signaling. | 
| + | - | nl | Mol Endocrinol 20(2):241-53 (2006) |
| 16 | 2006 | Growth hormone and its disorders. | 
| + | - | nl | Postgrad Med J 82(963):24-30 (2006) |
| 17 | 1964 | PHYSIOLOGICAL AND PATHOLOGICAL ROLES OF GROWTH HORMONE. | 
| + | - | nl | Postgrad Med J 40(-):470-8 (1964) |
| 18 | 2010 | Growth hormone: health considerations beyond height gain. | 
| + | - | nl | Pediatrics 125(4):e906-18 (2010) |
| 19 | 2007 | Variable phenotypes in familial isolated growth hormone deficiency caused by a G6664A mutation in the GH-1 gene. | 
| + | - | nl | J Clin Endocrinol Metab 92(11):4387-93 (2007) |
| 20 | 2002 | Familial isolated growth hormone deficiency: genetics and pathophysiology. | 
| + | - | nl | Endocr J 49(3):265-72 (2002) |
| 21 | 2009 | American Association of Clinical Endocrinologists medical guidelines for clinical practice for growth hormone use in growth hormone-deficient adults and transition patients - 2009 update: executive summary of recommendations. | 
| + | - | nl | Endocr Pract 15(6):580-6 (2009) |
| 22 | 2004 | Genetic defects in GH synthesis and secretion. | 
| + | - | nl | Eur J Endocrinol 151 Suppl 1(-):S3-9 (2004) |
| 23 | 2004 | New molecular mechanisms of GH resistance. | 
| + | - | nl | Eur J Endocrinol 151 Suppl 1(-):S11-5 (2004) |
| 24 | 2004 | The regulation of GH secretion by sex steroids. | 
| + | - | nl | Eur J Endocrinol 151 Suppl 3(-):U95-100 (2004) |
| 25 | 2003 | Central effects of the somatotropic system. | 
| + | - | nl | Eur J Endocrinol 149(5):377-92 (2003) |
| 26 | 2007 | Idiopathic short stature: will genetics influence the choice between GH and IGF-I therapy? | 
| + | - | nl | Eur J Endocrinol 157 Suppl 1(-):S33-7 (2007) |
| 27 | 2007 | Metabolic implications of GH treatment in small for gestational age. | 
| + | - | nl | Eur J Endocrinol 157 Suppl 1(-):S47-50 (2007) |
| 28 | 2007 | Consensus guidelines for the diagnosis and treatment of adults with GH deficiency II: a statement of the GH Research Society in association with the European Society for Pediatric Endocrinology, Lawson Wilkins Society, European Society of Endocrinology, Japan Endocrine Society, and Endocrine Society of Australia. | 
| + | - | nl | Eur J Endocrinol 157(6):695-700 (2007) |
| 29 | 2009 | Growth hormone and insulin-like growth factor-I in the transition from normal mammary development to preneoplastic mammary lesions. | 
| + | - | nl | Endocr Rev 30(1):51-74 (2009) |
| 30 | 2004 | Justified and unjustified use of growth hormone. | 
| + | - | nl | Postgrad Med J 80(948):577-80 (2004) |
| 31 | 2002 | Clinical effectiveness and cost-effectiveness of growth hormone in children: a systematic review and economic evaluation. | 
| + | - | nl | Health Technol Assess 6(18):1-168 (2002) |
| 32 | 2007 | Growth hormone therapy in children and adults. | 
| + | - | nl | Pharmacol Rep 59(5):500-16 (2007) |
| 33 | 2002 | Regulation of human growth hormone secretion and its disorders. | 
| + | - | nl | Intern Med 41(1):7-13 (2002) |
| 34 | 2010 | Atrazine binds to the growth hormone-releasing hormone receptor and affects growth hormone gene expression. | 
| + | - | nl | Environ Health Perspect 118(10):1400-5 (2010) |
| 35 | 2007 | Insulin like growth factors and growth hormone deficiency. | 
| + | - | nl | Indian Pediatr 44(5):349-53 (2007) |
| 36 | 2006 | Advances in pediatric growth hormone therapy: IGF-I-based dosing. | 
| + | - | nl | Indian Pediatr 43(7):577-81 (2006) |